Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants
PediatriaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- The Cochrane database of systematic reviews
- Publicado em
- 28 abr 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants
Yao Mun Choo, Ke Xin Yip, Michelle Fiander, Azanna Ahmad Kamar, Tengku Ain Kamalden, Kenneth Tan, Nai Ming Lai
Descritores MeSH
- Zeaxanthins
- Antioxidants
- Infant, Premature
- Infant, Premature, Diseases
- Lutein
- Dietary Supplements
- Randomized Controlled Trials as Topic
- Cerebral Intraventricular Hemorrhage
- Retinopathy of Prematurity
- Enterocolitis, Necrotizing
Veja também
Estudos relacionados
- Cerebral near-infrared spectroscopy monitoring for prevention of death or neurodevelopmental disability in very preterm infants
- Early erythropoiesis-stimulating agents in preterm or low-birthweight infants
- Effect of enteral supplementation of DHA with or without ARA in preterm infants: a meta-analysis
- Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants